Continental Hospitals Hosts National GI Conference with Mayo Clinic and Oxford Experts

Continental Hospitals successfully hosted a National Gastrointestinal (GI) Conference 2024 in collaboration with experts from Mayo Clinic and the University of Oxford. The conference, themed "From Bench to Bedside," aimed to bridge the gap between research and practical application in GI care.

The three-day event, held from June 28 to 30, 2024, at the Sheraton Hotel in Hyderabad's Financial District, brought together renowned global experts from Mayo Clinic in the USA, Oxford, London, and India. They delivered insightful presentations on advanced diagnostics, innovative therapies, and personalized treatment strategies, equipping healthcare professionals with the latest tools and knowledge to elevate patient care standards nationwide.

Highlighting the significance of the collaboration, Dr. Guru N. Reddy, Founder and Chairman of Continental Hospitals and Program Chairman for the National GI Conference 2024, said, "This partnership reflects our commitment to advancing healthcare through innovation and international collaboration for patient care. Precision healthcare is rapidly shifting from yesterday's prospects to today's reality, and the future of medicine lies in a multi-faceted approach to diagnose and treat patients. Improper diagnosis and treatment will increase the burden of care in our country."

Prof. John B. Kisiel, Professor of Medicine and Consultant in Gastrointestinal Neoplasia and Inflammatory Bowel Disease clinics at the Division of Gastroenterology & Hepatology, Mayo Clinic in Rochester, emphasized the importance of the conference, stating, "This national conference is a valuable platform to discuss new discoveries that will impact future medical practices. By bringing together experts from diverse backgrounds, we can help clinicians understand these changes and implement them in their clinics, ultimately delivering personalized, broad, and preventive care to patients."

Other distinguished speakers at the conference included Dr. Jagannath P, Director of the Continental Cancer Centre and former President of the International Hepato-Pancreato Biliary Association, USA; Prof. Prasad Iyer, Professor of Medicine, Chair of the Division of Gastroenterology and Hepatology, and Medical Director of the Mayo Hub Trial Innovation Network; Prof. Anna Schuh, Professor of Molecular Diagnostics at the Department of Oncology, University of Oxford, UK, and Founder and Clinical Director of the Oxford Molecular Diagnostic Centre; and Prof. P. Shravan Kumar, Professor and Head of the Department of Gastroenterology at Gandhi Medical College, Hyderabad.

The conference aimed to empower physicians, share knowledge, and lower healthcare costs, particularly in gastrointestinal, liver, and noncommunicable disorders. It focused on the impact of the genetic revolution on medicine, from research to clinical applications.